secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001860742-24-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q4 rev $1.17B (+18% YoY); guides FY 2024 rev $4.6-4.7B
--------------------------------------------------------------------

- Q4 2023 revenue $1.173B (+18% YoY); full-year revenue $4.146B (+10% YoY).
- GAAP net loss attributable to BLCO: Q4 $54M, FY $260M; prior year Q4 loss $1M, FY income $6M.
- Adjusted EBITDA Q4 $231M (+$50M YoY); FY $738M (+$18M YoY). 2024 guidance: $840-$890M.
- Pharmaceuticals segment revenue up 67% in Q4 driven by XIIDRA acquisition and MIEBO launch.
- Cash flow from operations negative $17M for FY 2023 vs +$345M in 2022 due to inventory build and timing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000003/0001860742-24-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000003/blco-20240221.htm
  HTML page:      https://secwatch.observer/filing/0001860742-24-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer